Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy

  • Authors:
    • Anna Ketola
    • Ann-Marie Määttä
    • Tiina Pasanen
    • Kirsi Tulimäki
    • Jarmo Wahlfors
  • View Affiliations

  • Published online on: May 1, 2004     https://doi.org/10.3892/ijmm.13.5.705
  • Pages: 705-710
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Osteosarcoma and chondrosarcoma, the most prevalent primary malignant tumors of the bone, have been demonstrated to be potential target diseases for herpes simplex virus type 1 thymidine kinase (HSV-TK)/ganciclovir (GCV) suicide gene therapy. However, the utility of this gene therapy form for bone tumor cells has not been studied systematically. In this report we show, with the aid of three osteosarcoma cell lines (Saos-2, U-2-OS and MG-63) and one chondrosarcoma cell line (SW1353) that: i) these tumor cells were permissive for adenovirus- or lentivirus-mediated gene delivery; ii) the cell lines appeared to be good or excellent targets for HSV-TK/GCV gene therapy; and iii) the extent of HSV-TK/GCV cytotoxic effect correlated with the presence of the ‘bystander effect’ in these cells. Our results also suggest that lentiviruses are potential vectors for bone cancer gene therapy. They transduced all four cell lines with high efficiency and provided HSV-TK expression level that was sufficient for cytotoxicity and bystander effect comparable to that obtained with adenovirus vectors.

Related Articles

Journal Cover

May 2004
Volume 13 Issue 5

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ketola A, Määttä A, Pasanen T, Tulimäki K and Wahlfors J: Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy. Int J Mol Med 13: 705-710, 2004
APA
Ketola, A., Määttä, A., Pasanen, T., Tulimäki, K., & Wahlfors, J. (2004). Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy. International Journal of Molecular Medicine, 13, 705-710. https://doi.org/10.3892/ijmm.13.5.705
MLA
Ketola, A., Määttä, A., Pasanen, T., Tulimäki, K., Wahlfors, J."Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy". International Journal of Molecular Medicine 13.5 (2004): 705-710.
Chicago
Ketola, A., Määttä, A., Pasanen, T., Tulimäki, K., Wahlfors, J."Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy". International Journal of Molecular Medicine 13, no. 5 (2004): 705-710. https://doi.org/10.3892/ijmm.13.5.705